Skip to contentClarengateINTELLIGENCE
Companies/02147149

Hel Limited

Private Limited Company · Hemel Hempstead

ActiveUnited KingdomIncorporated 1987Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2017-06-30

IXBRL · 162 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2016-07-01 to 2017-06-30
Extraction status
Legacy / not assessed
Numeric facts
98
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0052_02147149_20170630
Source archive
Accounts_Monthly_Data-March2018.zip

Registered details

02147149
Status
Active
Type
Private Limited Company
Incorporated
1987-07-14
Jurisdiction
—
Registered office
UNIT 2 CENTRO, BOUNDARY WAY, HEMEL HEMPSTEAD, HP2 7SU, ENGLAND

Classification

1 SIC codes
23011

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

5 matched grants
SynBioCO2 - A synthetic biology platform for biomanufacturing with carbon dioxideActive
EPSRC · Research Grant · 2023-12-01 – 2027-05-30 · with 3 other participants
£355,733
whole project
University of SheffieldleadHEL LimitedScionUniversity of Massachusetts Amherst
Achieving better chemistry faster through thermoelectric promotion of catalysisLead
Innovate UK · Feasibility Studies · 2017-12-01 – 2018-11-30 · with 2 other participants
£100,216
awarded
Hel Limitedlead£100,216
Cranfield University£74,306
Photo-Electro: Transforming Chemical Synthesis, Discovery and Manufacture
EPSRC · Research Grant · 2017-02-06 – 2023-08-04 · with 43 other participants
£6,486,389
whole project
University Of NottinghamleadAnsys, IncANSYS (International)ArcinovaArc Trinova Ltd (Arcinova)AstrazenecaAstraZenecaAsyntAsynt LtdBeta Technology LtdBritestBritest LimitedCambridge Reactor DesignCambridge Reactor Design LtdCentre for Process InnovationCentre for Process Innovation (CPI)Eli Lilly and Company (International)Eli Lilly & Company LtdEnlumo LtdGivaudanGivaudan (International)GlaxoSmithKline (GSK)GskHel GroupHEL LimitedHuvepharmaJohnson MattheyKnowledge Transfer NetworkKnowledge Transfer Network LimitedMerckMerck Chemicals Ltd UKMettler-Toledo Auto ChemNovartisNovartis Pharma AGSanofiSanofiAventis Deutschland GmbHSiemens Process Systems Engineering LtdSyngentaSyngenta International AGThomas Swan and Co LtdThomas Swan & Co LimitedUnileverUnilever UK Central Resources LimitedUniqsis Ltd
Continuous Chemical Manufacture with Light (C2ML)
EPSRC · Research Grant · 2014-03-31 – 2016-03-30 · with 12 other participants
£294,044
whole project
University Of NottinghamleadAstraZenecaBritest LimitedChemistry InnovationEnlumo LtdGskHEL LimitedNovartis Pharmaceuticals UK LtdSanofiAventis Deutschland GmbHSyngentaThomas Swan and Co LtdThomas Swan & Co LimitedUniqsis Ltd
Development of an Innovative, Continuous Ozonolysis Platform for Sustainable Chemical Manufacturing
Innovate UK · Collaborative R&D · with 3 other participants